Roy Buchanan
Stock Analyst at JMP Securities
(0.85)
# 2,811
Out of 4,412 analysts
31
Total ratings
30%
Success rate
-25.35%
Average return
Main Sectors:
Top Industries:
11 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABUS Arbutus Biopharma | Reiterates: Market Outperform | $4 | $2.78 | +43.88% | 4 | Apr 4, 2024 | |
| GRTS Gritstone bio | Maintains: Market Outperform | $4 → $5 | $0.81 | +520.27% | 2 | Apr 2, 2024 | |
| ANTX AN2 Therapeutics | Upgrades: Market Outperform | $6 | $2.37 | +153.16% | 3 | Apr 2, 2024 | |
| INO Inovio Pharmaceuticals | Initiates: Market Outperform | $12 | $11.50 | +4.35% | 1 | Jan 4, 2024 | |
| ENTA Enanta Pharmaceuticals | Maintains: Outperform | $42 → $23 | $13.25 | +73.58% | 6 | Nov 21, 2023 | |
| DVAX Dynavax Technologies | Maintains: Market Outperform | $25 → $27 | $11.34 | +138.10% | 5 | Nov 3, 2023 | |
| CVAC CureVac | Maintains: Outperform | $34 → $24 | $2.52 | +852.38% | 4 | Apr 26, 2023 | |
| ESPR Esperion Therapeutics | Reiterates: Market Outperform | $15 | $1.99 | +653.77% | 1 | Mar 6, 2023 | |
| ARGX argenx SE | Maintains: Market Outperform | $443 → $448 | $375.29 | +19.37% | 2 | Mar 3, 2023 | |
| CRMD CorMedix | Maintains: Market Perform | $14 → $16 | $5.28 | +203.03% | 1 | Mar 1, 2023 | |
| IBIO iBio, Inc. | Downgrades: Market Perform | n/a | $1.66 | - | 2 | Feb 16, 2023 |
Arbutus Biopharma
Apr 4, 2024
Reiterates: Market Outperform
Price Target: $4
Current: $2.78
Upside: +43.88%
Gritstone bio
Apr 2, 2024
Maintains: Market Outperform
Price Target: $4 → $5
Current: $0.81
Upside: +520.27%
AN2 Therapeutics
Apr 2, 2024
Upgrades: Market Outperform
Price Target: $6
Current: $2.37
Upside: +153.16%
Inovio Pharmaceuticals
Jan 4, 2024
Initiates: Market Outperform
Price Target: $12
Current: $11.50
Upside: +4.35%
Enanta Pharmaceuticals
Nov 21, 2023
Maintains: Outperform
Price Target: $42 → $23
Current: $13.25
Upside: +73.58%
Dynavax Technologies
Nov 3, 2023
Maintains: Market Outperform
Price Target: $25 → $27
Current: $11.34
Upside: +138.10%
CureVac
Apr 26, 2023
Maintains: Outperform
Price Target: $34 → $24
Current: $2.52
Upside: +852.38%
Esperion Therapeutics
Mar 6, 2023
Reiterates: Market Outperform
Price Target: $15
Current: $1.99
Upside: +653.77%
argenx SE
Mar 3, 2023
Maintains: Market Outperform
Price Target: $443 → $448
Current: $375.29
Upside: +19.37%
CorMedix
Mar 1, 2023
Maintains: Market Perform
Price Target: $14 → $16
Current: $5.28
Upside: +203.03%
iBio, Inc.
Feb 16, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $1.66
Upside: -